EuroChem Pre-Reports Selected IFRS Financial Information for Q3 2010
OREANDA-NEWS. November 19, 2010.
|
Q3 2010 |
Q3 2009 |
Chng |
9M 2010 |
9M 2009 |
Chng | |||||
RUR bn |
USD m |
RUR bn |
USD m |
RUR bn |
USD m |
RUR bn |
USD m | ||||
Revenue |
24.3 |
792 |
18.8 |
599 |
plus29% |
69.7 |
2,305 |
55.2 |
1,701 |
plus26% | |
EBITDA |
6.3 |
207 |
3.1 |
100 |
plus102% |
19.4 |
640 |
13.5 |
414 |
plus44% | |
Net profit |
4.8 |
156 |
3.3 |
104 |
plus46% |
11.7 |
388 |
8.9 |
274 |
plus32% | |
Cash from operations |
6.0 |
197 |
3.4 |
108 |
plus82% |
17.2 |
567 |
13.0 |
400 |
plus31% | |
|
30 September 2010 |
31 December 2009 | |||||||||
Net Debt/EBITDA |
1.59 |
2.21 | |||||||||
Average RUR/USD exchange rate for periods: Q3 2010: 30.62; Q3 2009: 31.33; 9M 2010: 30.25; 9M 2009: 32.48
EuroChem is today publishing certain features of its consolidated financial performance during the first 9 months of 2010, several days in advance of the planned publication of its auditor-reviewed IFRS financial statements for this period. The company has taken this step in connection with the release of a marketing research document linked to the ongoing placement of Rouble-denominated bonds by EuroChem that contains references to these financial statements.
For the third quarter of 2010, EuroChem expects to report a consolidated IFRS net profit of RUR 4.8bn, an increase of 46% from RUR 3.3bn for Q3 2009. Consolidated revenues also increased 29% to RUR 24.3bn in Q3 2010 from RUR 18.8bn in Q3 2009. Net profit for the first nine months of 2010 amounted to RUR 11.7bn, up 32% from RUR 8.9bn in 9M 2009.
EuroChem’s gross margin in Q3 2010 was 52% on gross profit of RUR 12.6bn, compared to a 43% / RUR 8.0bn result for Q3 2009. EBITDA was RUR 6.3bn for the third quarter of 2010, increasing 102% vs. RUR 3.1bn in Q3 2009. The EBITDA margin for the period was 26%, compared to 17% for Q3 2009.
Fertilizer sales volumes in the third quarter of 2010 were flat vs. Q3 2009, with a moderate increase in phosphate volumes offset by a small decrease in nitrogen products. Combined nitrogen and phosphate sales volumes amounted to 1,898 thousand metric tonnes (KMT) (excl. iron ore and baddeleyite). Similarly, the company’s sales of iron ore in the third quarter were virtually unchanged at 1,549 KMT in Q3 2010 compared to 1,556 KMT in Q3 2009.
The Company expects strong financial performance to continue over Q4 2010 and Q1 2011 on demand-driven price strength in nitrogen and phosphate fertilizers against the background of tight supply.
The table below contains details of the Q3 2010 and 9 months’ 2010 performance of EuroChem which have been used in the marketing document expected to be released later today:
EuroChem: selected IFRS consolidated financials and ratios | |||
|
9M2010 |
9M2009 |
Change |
Revenue, RUR bn |
69.7 |
55.2 |
plus26% |
Gross profit, RUR bn |
34.8 |
24.3 |
plus43% |
Gross margin, % |
49.9 |
44.0 |
plus5.9 bps |
EBITDA, RUR bn |
19.4 |
13.5 |
plus44% |
EBITDA margin, % |
27.8 |
24.4 |
plus3 bps |
Net profit, RUR bn |
11.7 |
8.9 |
plus32% |
Net margin, % |
16.8 |
16.1 |
plus0.7 bps |
Net cash – operating activities, RUR bn |
17.2 |
13.0 |
plus32% |
Net cash – investing activities, RUR bn* |
(13.1)* |
(22.8)* |
-42% |
Net cash financing activities, RUR bn |
(8.4) |
(3.6) |
plus2.3х |
Net decrease in cash and cash equivalents, RUR bn |
(4.6) |
(11.7) |
-61% |
|
30 Sept. 2010 |
31 Dec. 2009 |
Change |
Total assets, RUR bn |
136.4 |
128.8 |
plus6% |
Total equity, RUR bn |
84.0 |
73.2 |
plus15% |
Total gross debt, RUR bn |
42.4 |
47.8 |
-11% |
Cash and cash equivalents, RUR bn** |
6.7 |
11.4 |
-41% |
Total gross debt/LTM***EBITDA, times |
1.89 |
2.89 |
n/a |
Total gross debt/Total assets |
0.31 |
0.37 |
n/a |
Total gross debt/Total equity |
0.50 |
0.65 |
n/a |
Net debt, RUR bn |
35.9 |
36.5 |
-2% |
Net debt/LTM***EBITDA, times |
1.59 |
2.21 |
n/a |
* Including net cash inflows of RUR 0.7bn (9M 2009: net cash outflows of RUR 9.7bn) arising from transactions related to the shares of K plusS AG (the purchase and sale of shares, dividends from the shares, proceeds from the sale of derivatives linked to the shares and movements in loan balances granted for the purposes of the shares purchase).
** Including current and non-current restricted cash.
*** Last twelve months.
Комментарии